StockData
Cellyan Biotechnology Co., Ltd logo

Cellyan Biotechnology Co., Ltd (HKPD) shareholders

HKPDNasdaqWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends March 31
Số liệu tài chính tới năm tài chính 2026, năm kết thúc ngày Mar 31, 2026Last filing: 20-F on Aug 7, 2026Score 3/30
$1.52−0.09 (-5.30%)

Close on Nov 17, 2026Market cap $24.93MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
1.5%
0M of 16M shares
Institutional holders
6
3 new, 1 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Liying Wang
Joint filing with TUTU Business Services Limited (65.00%)
7,150,00065.00%13D (active)Oct 6, 2025
Lap Sun Wong6,244,96156.77%13G (passive)Mar 31, 2025
Atlantic Health Century International Group617,8505.62%13G (passive)Mar 31, 2025
Pacific Health Century International Group617,8505.62%13G (passive)Mar 31, 2025

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of HKPDValueChange% of portfolio
StoneX Group Inc.102,3100.63%$52.36K+62,9150.00%
Jane Street Group, LLC49,0870.30%$18.65KNew0.00%
Hrt Financial LP41,8240.26%$15.00KNew0.00%
XTX Topco Ltd38,9300.24%$14.79KNew0.00%
Clear Street Group Inc.12,0190.07%$4.57K–0.00%
UBS Group AG1,0810.01%$411+9710.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 202660M1.5%3 / 20 / 10M0M
Q1 202640M0.4%0 / 03 / 00M0M
Q4 202540M0.5%2 / 10 / 00M0M
Q3 202520M0.1%1 / 01 / 40M0M
Q2 202560M0.4%3 / 12 / 10M0M
Q1 202540M0.3%4 / 00 / 00M0M

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Chenyu Andy LiangCEO and Director––Jun 8, 2026
Zifeng WangChief Strategy Officer––Jun 9, 2026
Shu LiuCFO––Jun 8, 2026
Kam Leung CHANDirector––Jun 12, 2026
Lap Sun WongDirector18,4680.11%Jun 10, 2026
Jingyan WuDirector––Jun 8, 2026
Mike Yao ZhouDirector––Jun 8, 2026

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
0.57%
0M shares short
Days to cover
1.0
At 0M shares a day
Change since last report
-91.4%
From 0M shares
Short volume, 20 days
41.6%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Cellyan Biotechnology's stock actually held short. Settlement fails (shares not delivered on time) peaked at 354,881 shares on Sep 11, 2026 over the last 90 days.

See a number that looks wrong?